Cover Image
市場調查報告書

亞太地區的血液檢驗市場未來展望

Asia-Pacific Haematology Market Outlook to 2021

出版商 GlobalData 商品編碼 348479
出版日期 內容資訊 英文 179 Pages
訂單完成後即時交付
價格
Back to Top
亞太地區的血液檢驗市場未來展望 Asia-Pacific Haematology Market Outlook to 2021
出版日期: 2015年10月05日 內容資訊: 英文 179 Pages
簡介

本報告提供亞太地區各國 (澳洲·中國·印度·日本·韓國) 的血液檢驗的市場相關分析,提供您地區整體市場規模趨勢預測 (以金額為準,過去·今後8年份) ,及各國層級之詳細趨勢,主要企業·流通管道的市場佔有率,主要開發中產品的目前臨床實驗情形,主要企業簡介,最新的市場動靜(資本交易等)等相關之調查與考察。

第1章 目錄

第2章 簡介

  • 本報告概要
  • 遺傳基因檢驗市場明細
  • 分析對象市場定義

第3章 亞太地區的血液檢驗市場

  • 市場收益額:總額 (總計15年份)
  • 市場收益額:不同分類的明細 (總計15年份)
  • 市場收益額的實際成果值:以金額為準 (過去8年份)
  • 市場收益額的預測值:以金額為準 (今後8年份)
  • 市場收益額佔有率:各企業

第4章 澳洲的血液檢驗市場

  • 市場收益額的實際成果值:以金額為準 (過去8年份)
  • 市場收益額的預測值:以金額為準 (今後8年份)
    • 血液細胞計數器的市場趨勢 (過去·今後8年份)
    • 迅速/POC (照護現場) 血液檢驗的市場趨勢 (過去·今後8年份)
    • 血液檢驗用試劑的市場趨勢 (過去·今後8年份)
    • 止血檢驗的市場趨勢 (過去·今後8年份)
    • 免疫血液學檢查的市場趨勢 (過去·今後8年份)
  • 市場收益額佔有率:各流通管道
  • 市場收益額佔有率:各企業

第5章 中國的血液檢驗市場

第6章 印度的血液檢驗市場

第7章 日本的血液檢驗市場

第8章 韓國的血液檢驗市場

第9章 亞太地區的血液檢驗市場:主要企業概要

  • Sysmex
  • Siemens Healthcare
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • 堀場製作所
  • Abbott Laboratories
  • 日本光電工業
  • Transasia Bio-Medicals Ltd.
  • Mindray Medical International Limited
  • bioMerieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Immucor, Inc.

第10章 血液檢驗市場開發中產品

第11章 近幾年趨勢

  • 公佈財報 (全10件)
  • 法規·規定趨勢 (1件)
  • 其他主要動向 (1件)
  • 策略·產業計畫 (1件)

第12章 附錄

圖表一覽

目錄
Product Code: GDMECR0337DB

GlobalData's new report, "Asia-Pacific Haematology Market Outlook to 2021", provides key market data on the Asia-Pacific Haematology market. The report provides value, in millions of US dollars within market segments - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Haematology market includes Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology.
  • Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Haematology market.
  • Global corporate-level profiles of key companies operating within the Asia-Pacific Haematology market.
  • Key players covered include Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., Abbott Laboratories and bioMerieux S.A..

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Haematology Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Haematology Market, Asia-Pacific

  • 3.1. Haematology Market, Asia-Pacific, Revenue ($m), 2007-2021
  • 3.2. Haematology Market, Asia-Pacific, Category Comparison by Revenue ($m), 2007-2021
  • 3.3. Haematology Market, Asia-Pacific, Revenue ($m), 2007-2014
  • 3.4. Haematology Market, Asia-Pacific, Revenue ($m), 2014-2021
  • 3.5. Haematology Market, Asia-Pacific, Company Share by Revenue ($m), 2014

4. Haematology Market, Australia

  • 4.1. Haematology Market, Australia, Revenue ($m), 2007-2014
  • 4.2. Haematology Market, Australia, Revenue ($m), 2014-2021
    • 4.2.1. Haematology Cell Counters Market, Australia, Revenue ($m), by Segment, 2007-2014
    • 4.2.2. Haematology Rapid Tests & POC Market, Australia, Revenue ($m), by Segment, 2007-2014
    • 4.2.3. Haematology Reagents Market, Australia, Revenue ($m), by Segment, 2007-2014
    • 4.2.4. Haemostasis Market, Australia, Revenue ($m), by Segment, 2007-2014
    • 4.2.5. Immunohaematology Market, Australia, Revenue ($m), by Segment, 2007-2014
    • 4.2.6. Haematology Cell Counters Market, Australia, Revenue ($m), by Segment, 2014-2021
    • 4.2.7. Haematology Rapid Tests & POC Market, Australia, Revenue ($m), by Segment, 2014-2021
    • 4.2.8. Haematology Reagents Market, Australia, Revenue ($m), by Segment, 2014-2021
    • 4.2.9. Haemostasis Market, Australia, Revenue ($m), by Segment, 2014-2021
    • 4.2.10. Immunohaematology Market, Australia, Revenue ($m), by Segment, 2014-2021
  • 4.3. Haematology Market, Australia, Distribution Share by Revenue ($m), 2013-2014
  • 4.4. Haematology Market, Australia, Company Share by Revenue ($m), 2014

5. Haematology Market, China

  • 5.1. Haematology Market, China, Revenue ($m), 2007-2014
  • 5.2. Haematology Market, China, Revenue ($m), 2014-2021
    • 5.2.1. Haematology Cell Counters Market, China, Revenue ($m), by Segment, 2007-2014
    • 5.2.2. Haematology Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2007-2014
    • 5.2.3. Haematology Reagents Market, China, Revenue ($m), by Segment, 2007-2014
    • 5.2.4. Haemostasis Market, China, Revenue ($m), by Segment, 2007-2014
    • 5.2.5. Immunohaematology Market, China, Revenue ($m), by Segment, 2007-2014
    • 5.2.6. Haematology Cell Counters Market, China, Revenue ($m), by Segment, 2014-2021
    • 5.2.7. Haematology Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2014-2021
    • 5.2.8. Haematology Reagents Market, China, Revenue ($m), by Segment, 2014-2021
    • 5.2.9. Haemostasis Market, China, Revenue ($m), by Segment, 2014-2021
    • 5.2.10. Immunohaematology Market, China, Revenue ($m), by Segment, 2014-2021
  • 5.3. Haematology Market, China, Distribution Share by Revenue ($m), 2013-2014
  • 5.4. Haematology Market, China, Company Share by Revenue ($m), 2014

6. Haematology Market, India

  • 6.1. Haematology Market, India, Revenue ($m), 2007-2014
  • 6.2. Haematology Market, India, Revenue ($m), 2014-2021
    • 6.2.1. Haematology Cell Counters Market, India, Revenue ($m), by Segment, 2007-2014
    • 6.2.2. Haematology Rapid Tests & POC Market, India, Revenue ($m), by Segment, 2007-2014
    • 6.2.3. Haematology Reagents Market, India, Revenue ($m), by Segment, 2007-2014
    • 6.2.4. Haemostasis Market, India, Revenue ($m), by Segment, 2007-2014
    • 6.2.5. Immunohaematology Market, India, Revenue ($m), by Segment, 2007-2014
    • 6.2.6. Haematology Cell Counters Market, India, Revenue ($m), by Segment, 2014-2021
    • 6.2.7. Haematology Rapid Tests & POC Market, India, Revenue ($m), by Segment, 2014-2021
    • 6.2.8. Haematology Reagents Market, India, Revenue ($m), by Segment, 2014-2021
    • 6.2.9. Haemostasis Market, India, Revenue ($m), by Segment, 2014-2021
    • 6.2.10. Immunohaematology Market, India, Revenue ($m), by Segment, 2014-2021
  • 6.3. Haematology Market, India, Distribution Share by Revenue ($m), 2013-2014
  • 6.4. Haematology Market, India, Company Share by Revenue ($m), 2014

7. Haematology Market, Japan

  • 7.1. Haematology Market, Japan, Revenue ($m), 2007-2014
  • 7.2. Haematology Market, Japan, Revenue ($m), 2014-2021
    • 7.2.1. Haematology Cell Counters Market, Japan, Revenue ($m), by Segment, 2007-2014
    • 7.2.2. Haematology Rapid Tests & POC Market, Japan, Revenue ($m), by Segment, 2007-2014
    • 7.2.3. Haematology Reagents Market, Japan, Revenue ($m), by Segment, 2007-2014
    • 7.2.4. Haemostasis Market, Japan, Revenue ($m), by Segment, 2007-2014
    • 7.2.5. Immunohaematology Market, Japan, Revenue ($m), by Segment, 2007-2014
    • 7.2.6. Haematology Cell Counters Market, Japan, Revenue ($m), by Segment, 2014-2021
    • 7.2.7. Haematology Rapid Tests & POC Market, Japan, Revenue ($m), by Segment, 2014-2021
    • 7.2.8. Haematology Reagents Market, Japan, Revenue ($m), by Segment, 2014-2021
    • 7.2.9. Haemostasis Market, Japan, Revenue ($m), by Segment, 2014-2021
    • 7.2.10. Immunohaematology Market, Japan, Revenue ($m), by Segment, 2014-2021
  • 7.3. Haematology Market, Japan, Distribution Share by Revenue ($m), 2013-2014
  • 7.4. Haematology Market, Japan, Company Share by Revenue ($m), 2014

8. Haematology Market, South Korea

  • 8.1. Haematology Market, South Korea, Revenue ($m), 2007-2014
  • 8.2. Haematology Market, South Korea, Revenue ($m), 2014-2021
    • 8.2.1. Haematology Cell Counters Market, South Korea, Revenue ($m), by Segment, 2007-2014
    • 8.2.2. Haematology Rapid Tests & POC Market, South Korea, Revenue ($m), by Segment, 2007-2014
    • 8.2.3. Haematology Reagents Market, South Korea, Revenue ($m), by Segment, 2007-2014
    • 8.2.4. Haemostasis Market, South Korea, Revenue ($m), by Segment, 2007-2014
    • 8.2.5. Immunohaematology Market, South Korea, Revenue ($m), by Segment, 2007-2014
    • 8.2.6. Haematology Cell Counters Market, South Korea, Revenue ($m), by Segment, 2014-2021
    • 8.2.7. Haematology Rapid Tests & POC Market, South Korea, Revenue ($m), by Segment, 2014-2021
    • 8.2.8. Haematology Reagents Market, South Korea, Revenue ($m), by Segment, 2014-2021
    • 8.2.9. Haemostasis Market, South Korea, Revenue ($m), by Segment, 2014-2021
    • 8.2.10. Immunohaematology Market, South Korea, Revenue ($m), by Segment, 2014-2021
  • 8.3. Haematology Market, South Korea, Distribution Share by Revenue ($m), 2013-2014
  • 8.4. Haematology Market, South Korea, Company Share by Revenue ($m), 2014

9. Overview of Key Companies in Asia-Pacific Haematology Market

  • 9.1. Sysmex Corporation
    • 9.1.1. Company Overview
  • 9.2. Siemens Healthcare
    • 9.2.1. Company Overview
  • 9.3. Danaher Corporation
    • 9.3.1. Company Overview
  • 9.4. F. Hoffmann-La Roche Ltd.
    • 9.4.1. Company Overview
  • 9.5. Horiba, Ltd.
    • 9.5.1. Company Overview
  • 9.6. Abbott Laboratories
    • 9.6.1. Company Overview
  • 9.7. Nihon Kohden Corporation
    • 9.7.1. Company Overview
  • 9.8. Transasia Bio-Medicals Ltd.
    • 9.8.1. Company Overview
  • 9.9. Mindray Medical International Limited
    • 9.9.1. Company Overview
  • 9.10. bioMerieux S.A.
    • 9.10.1. Company Overview
  • 9.11. Bio-Rad Laboratories, Inc.
    • 9.11.1. Company Overview
  • 9.12. Immucor, Inc.
    • 9.12.1. Company Overview

10. Haematology Market Pipeline Products

11. Recent Developments

  • 11.1. Financial Announcements
    • 11.1.1. Jun 05, 2015: InVivo Therapeutics Announces Enrollment of Third Patient in Pilot Spinal Cord Injury Trial
    • 11.1.2. Jun 04, 2015: Guided Therapeutics Awarded Multiple Tenders for LuViva Advanced Cervical Scan Systems from Governments in Bangladesh
    • 11.1.3. Jun 04, 2015: Philips debuts Alice NightOne at-home sleep disorder diagnostic system
    • 11.1.4. Jun 04, 2015: FDA Clears NovaBay Pharmaceuticals' New High-Tech Device, intelli-Case, for Safely Disinfecting Contact Lenses with Hydrogen Peroxide
    • 11.1.5. Jun 04, 2015: Roche receives FDA clearance for the cobas Cdiff Test to detect Clostridium difficile
    • 11.1.6. May 15, 2015: Data Shows Improved Outcomes for Patients With St. Jude Medical Quadripolar CRT-P System
    • 11.1.7. May 11, 2015: Shionogi Reports Net Sales Of JPY274 Billion In Fiscal 2015
    • 11.1.8. Feb 02, 2015: Shionogi Reports Net Sales Of JPY200.3 Billion For The Nine Months Ended December 31, 2014
    • 11.1.9. Oct 29, 2014: SHIONOGI Announces Consolidated Financial Results For The Second Quarter Of Fiscal Year 2014
    • 11.1.10. Oct 10, 2014: Edan Introduces Acclarix Compact Ultrasound System at ANESTHESIOLOGY2014
  • 11.2. Legal And Regulatory
    • 11.2.1. Feb 15, 2015: Sysmex Philippines achieves ISO9001:2008 Certification
  • 11.3. Other Significant Developments
    • 11.3.1. Aug 18, 2015: Ortho Clinical Diagnostics Selects Model N for Global Deployment of Revvy Configure Price Quote for Medical Technologies
  • 11.4. Strategy And Business Planning
    • 11.4.1. Jul 07, 2015: Shionogi Announces the Continued Expansion of their Operations in Europe with the Launch of Shionogi Italy

12. Appendix

  • 12.1. Research Methodology
    • 12.1.1. Coverage
    • 12.1.2. Secondary Research
    • 12.1.3. Primary Research
    • 12.1.4. Company Share Analysis
    • 12.1.5. Distribution Share Analysis
  • 12.2. GlobalData Consulting
  • 12.3. Contact Us
  • 12.4. Disclaimer

List of Tables

  • Table 1: Haematology Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2007-2021
  • Table 2: Haematology Market, Asia-Pacific, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Table 3: Haematology Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2007-2014
  • Table 4: Haematology Market, Asia-Pacific, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Table 5: Haematology Market, Asia-Pacific, Company Share by Revenue ($m), USD Constant, 2014
  • Table 6: Haematology Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 7: Haematology Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 8: Haematology Cell Counters Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 9: Haematology Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 10: Haematology Reagents Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 11: Haemostasis Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 12: Immunohaematology Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 13: Haematology Cell Counters Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 14: Haematology Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 15: Haematology Reagents Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 16: Haemostasis Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 17: Immunohaematology Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 18: Haematology Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 19: Haematology Market, Australia, Company Share by Revenue ($m), USD Constant, 2014
  • Table 20: Haematology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 21: Haematology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 22: Haematology Cell Counters Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 23: Haematology Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 24: Haematology Reagents Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 25: Haemostasis Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 26: Immunohaematology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 27: Haematology Cell Counters Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 28: Haematology Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 29: Haematology Reagents Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 30: Haemostasis Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 31: Immunohaematology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 32: Haematology Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 33: Haematology Market, China, Company Share by Revenue ($m), USD Constant, 2014
  • Table 34: Haematology Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 35: Haematology Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 36: Haematology Cell Counters Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 37: Haematology Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 38: Haematology Reagents Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 39: Haemostasis Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 40: Immunohaematology Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 41: Haematology Cell Counters Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 42: Haematology Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 43: Haematology Reagents Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 44: Haemostasis Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 45: Immunohaematology Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 46: Haematology Market, India, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 47: Haematology Market, India, Company Share by Revenue ($m), USD Constant, 2014
  • Table 48: Haematology Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 49: Haematology Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 50: Haematology Cell Counters Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 51: Haematology Rapid Tests & POC Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 52: Haematology Reagents Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 53: Haemostasis Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 54: Immunohaematology Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 55: Haematology Cell Counters Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 56: Haematology Rapid Tests & POC Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 57: Haematology Reagents Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 58: Haemostasis Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 59: Immunohaematology Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 60: Haematology Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 61: Haematology Market, Japan, Company Share by Revenue ($m), USD Constant, 2014
  • Table 62: Haematology Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 63: Haematology Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 64: Haematology Cell Counters Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 65: Haematology Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 66: Haematology Reagents Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 67: Haemostasis Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 68: Immunohaematology Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 69: Haematology Cell Counters Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 70: Haematology Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 71: Haematology Reagents Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 72: Haemostasis Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 73: Immunohaematology Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 74: Haematology Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 75: Haematology Market, South Korea, Company Share by Revenue ($m), USD Constant, 2014
  • Table 76: Haematology Market Pipeline Products

List of Figures

  • Figure 1: Haematology Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2007-2021
  • Figure 2: Haematology Market, Asia-Pacific, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Figure 3: Haematology Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2007-2014
  • Figure 4: Haematology Market, Asia-Pacific, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Figure 5: Haematology Market, Asia-Pacific, Company Share (%) 2014
  • Figure 6: Haematology Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 7: Haematology Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 8: Haematology Cell Counters Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 9: Haematology Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 10: Haematology Reagents Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 11: Haemostasis Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 12: Immunohaematology Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 13: Haematology Cell Counters Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 14: Haematology Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 15: Haematology Reagents Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 16: Haemostasis Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 17: Immunohaematology Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 18: Haematology Market, Australia, Company Share (%) 2014
  • Figure 19: Haematology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 20: Haematology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 21: Haematology Cell Counters Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 22: Haematology Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 23: Haematology Reagents Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 24: Haemostasis Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 25: Immunohaematology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 26: Haematology Cell Counters Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 27: Haematology Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 28: Haematology Reagents Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 29: Haemostasis Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 30: Immunohaematology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 31: Haematology Market, China, Company Share (%) 2014
  • Figure 32: Haematology Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 33: Haematology Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 34: Haematology Cell Counters Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 35: Haematology Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 36: Haematology Reagents Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 37: Haemostasis Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 38: Immunohaematology Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 39: Haematology Cell Counters Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 40: Haematology Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 41: Haematology Reagents Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 42: Haemostasis Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 43: Immunohaematology Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 44: Haematology Market, India, Company Share (%) 2014
  • Figure 45: Haematology Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 46: Haematology Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 47: Haematology Cell Counters Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 48: Haematology Rapid Tests & POC Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 49: Haematology Reagents Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 50: Haemostasis Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 51: Immunohaematology Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 52: Haematology Cell Counters Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 53: Haematology Rapid Tests & POC Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 54: Haematology Reagents Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 55: Haemostasis Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 56: Immunohaematology Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 57: Haematology Market, Japan, Company Share (%) 2014
  • Figure 58: Haematology Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 59: Haematology Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 60: Haematology Cell Counters Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 61: Haematology Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 62: Haematology Reagents Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 63: Haemostasis Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 64: Immunohaematology Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 65: Haematology Cell Counters Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 66: Haematology Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 67: Haematology Reagents Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 68: Haemostasis Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 69: Immunohaematology Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 70: Haematology Market, South Korea, Company Share (%) 2014
Back to Top